- Home
- TSHA vs YRD Comparison
TSHA vs YRD Comparison
Compare TSHA & YRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSHA
- YRD
- Stock Information
- Founded
- TSHA 2019
- YRD 2012
- Country
- TSHA United States
- YRD China
- Employees
- TSHA N/A
- YRD N/A
- Industry
- TSHA Biotechnology: Pharmaceutical Preparations
- YRD Finance: Consumer Services
- Sector
- TSHA Health Care
- YRD Finance
- Exchange
- TSHA Nasdaq
- YRD Nasdaq
- Market Cap
- TSHA 403.7M
- YRD 415.5M
- IPO Year
- TSHA 2020
- YRD 2015
- Fundamental
- Price
- TSHA $2.00
- YRD $4.77
- Analyst Decision
- TSHA Strong Buy
- YRD
- Analyst Count
- TSHA 8
- YRD 0
- Target Price
- TSHA $6.63
- YRD N/A
- AVG Volume (30 Days)
- TSHA 5.4M
- YRD 194.1K
- Earning Date
- TSHA 11-13-2024
- YRD 11-20-2024
- Dividend Yield
- TSHA N/A
- YRD 4.14%
- EPS Growth
- TSHA N/A
- YRD N/A
- EPS
- TSHA N/A
- YRD 2.95
- Revenue
- TSHA $9,915,000.00
- YRD $802,340,579.00
- Revenue This Year
- TSHA N/A
- YRD N/A
- Revenue Next Year
- TSHA N/A
- YRD N/A
- P/E Ratio
- TSHA N/A
- YRD $1.62
- Revenue Growth
- TSHA N/A
- YRD 19.51
- 52 Week Low
- TSHA $1.19
- YRD $2.94
- 52 Week High
- TSHA $4.32
- YRD $9.20
- Technical
- Relative Strength Index (RSI)
- TSHA 42.15
- YRD 41.65
- Support Level
- TSHA $1.97
- YRD $4.66
- Resistance Level
- TSHA $2.72
- YRD $5.28
- Average True Range (ATR)
- TSHA 0.24
- YRD 0.35
- MACD
- TSHA -0.10
- YRD 0.01
- Stochastic Oscillator
- TSHA 4.48
- YRD 31.37
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.
About YRD Yiren Digital Ltd.
Yiren Digital Ltd is an advanced, AI-powered platform providing a comprehensive suite of financial and lifestyle services in China. its mission is to elevate customers' financial well-being and enhance their quality of life by delivering digital financial services, tailor-made insurance solutions, and premium lifestyle services. The company supports clients at various growth stages, addressing financing needs arising from consumption and production activities, while aiming to augment the overall well-being and security of individuals, families, and businesses.